Staar Surgical STAA Income Statement (2010-2026)

NASDAQ STAA
$23.36 -0.26 (-1.10%)
As of: Sep 10, 2026 · 12:34 PM EDT
Reported Financials

Staar Surgical Quarterly Income Statement

Periods 65 quarters
Latest Jul 2026

Staar Surgical reported revenue of $93.53M and net income of $8.06M for the quarter ended Jul 2026, up 111.0% year over year. This income statement covers 65 quarters of results from Jul 2010 through Jul 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jul2010 Oct2010 Dec2010 Apr2011 Jul2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Jan2014 Apr2014 Jul2014 Oct2014 Jan2015 Apr2015 Jul2015 Oct2015 Jan2016 Apr2016 Jul2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Jan2020 Apr2020 Jul2020 Oct2020 Jan2021 Apr2021 Jul2021 Oct2021 Dec2021 Apr2022 Jul2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Jan2026 Apr2026 Jul2026
Revenue & cost
Revenue
58.35M59.00M63.20M81.10M76.05M19.09M73.53M92.31M80.31M76.27M77.36M99.00M88.59M48.95M42.59M44.32M94.73M57.80M93.52M93.53M
Cost of RevenueCost of Rev
13.05M14.01M13.94M17.23M15.58M14.26M15.97M21.58M16.67M15.55M16.32M20.59M20.10M17.30M14.58M11.52M16.86M14.06M24.66M23.81M
Gross Profit
45.30M44.99M49.26M63.87M60.46M49.78M57.56M70.73M63.64M60.73M61.03M78.41M68.49M31.65M28.00M32.80M77.88M43.74M68.86M69.73M
Operating items
Research & DevelopmentR&D
18.18M17.07M17.27M24.23M23.13M24.22M26.35M32.28M26.61M26.52M26.71M31.00M28.87M28.44M26.95M26.28M23.46M25.84M24.51M26.94M
Selling, General & AdministrativeSG&A
37.46M37.61M37.15M46.85M46.76M48.82M54.76M62.13M57.34M50.32M63.32M66.51M62.80M59.56M85.41M62.76M59.38M66.58M60.88M59.63M
Restructuring CostsRestructuring
22.66M5.25M0.03M0.69M2.68M
Other Operating ExpensesOther Opex
-7.06M-0.70M
Operating ExpensesOpex
55.64M54.67M54.42M71.08M69.89M73.04M81.12M94.41M83.95M76.84M90.02M97.52M91.68M88.00M135.01M94.29M82.87M93.11M88.07M86.57M
Operating IncomeOp. Inc
7.84M7.38M12.11M17.02M13.71M0.96M2.80M8.60M6.29M10.40M-2.28M11.90M5.68M-27.91M-57.40M-29.96M18.49M-22.84M7.98M10.10M
EBIT
7.84M7.38M12.11M17.02M13.71M0.96M2.80M8.60M6.29M10.40M-2.28M11.90M5.68M-27.91M-57.40M-29.96M18.49M-22.84M7.98M10.10M
Non-operating items
Non Operating Interest Expenses
Interest & Investment IncomeInt & Inv Inc
-0.02M-0.00M-0.01M0.04M0.90M1.51M1.82M1.77M1.69M1.70M1.53M1.42M1.41M1.55M1.37M1.37M0.79M1.07M0.91M0.94M
Other Non Operating IncomeOther Non Op Inc.
-0.61M-1.85M-0.92M-1.86M-2.13M-2.09M0.06M-1.89M-1.38M-4.37M-2.30M-3.05M5.93M-4.49M1.42M2.56M-0.84M-0.54M-1.11M-0.41M
Non Operating IncomeNon Op. Inc.
-0.46M-0.41M-0.59M-1.55M-1.13M5.01M1.92M-0.10M0.45M3.33M0.07M-1.56M7.48M-2.42M2.92M4.05M0.30M2.19M0.24M0.92M
Net income details
EBT
7.38M22.54M11.53M15.47M12.58M31.34M4.72M8.49M6.75M60.13M-2.21M10.33M13.16M-74.14M-54.49M-25.91M18.79M-20.65M8.22M11.02M
Tax ProvisionsTaxes
1.36M1.82M1.93M2.43M2.31M2.90M2.01M2.43M1.93M5.98M1.13M2.96M3.18M3.89M-0.28M-9.10M9.91M-17.80M3.01M2.97M
Profit After TaxPAT
6.02M4.92M9.60M13.04M10.26M6.76M2.71M6.06M4.82M7.76M-3.34M7.38M9.98M-34.23M-54.21M-16.81M8.88M-18.31M5.21M8.06M
Income from Continuing OperationsIncome (Continuing)
6.02M20.72M9.60M13.04M10.26M28.45M2.71M6.06M4.82M54.14M-3.34M7.38M9.98M-78.03M-54.21M-16.81M8.88M-2.85M5.21M8.06M
Consolidated Net IncomeConsol Net Inc.
6.02M20.72M9.60M13.04M10.26M28.45M2.71M6.06M4.82M54.14M-3.34M7.38M9.98M-78.03M-54.21M-16.81M8.88M-2.85M5.21M8.06M
Income towards Parent CompanyParent Net Inc
6.02M20.72M9.60M13.04M10.26M28.45M2.71M6.06M4.82M54.14M-3.34M7.38M9.98M-78.03M-54.21M-16.81M8.88M-2.85M5.21M8.06M
Net Income towards Common StockholdersNet Income
6.02M20.72M9.60M13.04M10.26M28.45M2.71M6.06M4.82M54.14M-3.34M7.38M9.98M-78.03M-54.21M-16.81M8.88M-2.85M5.21M8.06M
Additional items
EPS (Basic)
0.130.440.200.270.210.590.060.130.101.12-0.070.150.20-1.59-1.10-0.340.18-0.060.100.16
EPS (Diluted)
0.120.420.190.260.210.580.050.120.101.10-0.070.150.20-1.59-1.10-0.340.18-0.060.100.16
Shares Outstanding
47.48M47.21M47.76M47.89M48.10M47.99M48.25M48.42M48.61M48.52M48.91M49.13M49.20M49.12M49.34M49.52M49.63M49.57M49.91M50.32M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
49.59M49.46M49.29M49.22M49.55M49.38M49.50M49.52M49.37M49.43M48.91M49.81M49.73M49.12M49.34M49.52M50.55M49.57M50.90M51.50M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
47.60M47.72M47.81M48.02M48.20M48.21M48.33M48.50M48.82M48.84M49.12M49.16M49.27M49.29M49.52M49.55M49.73M49.40M49.78M50.12M
EBITDA
7.84M7.38M12.11M17.02M13.71M0.96M2.80M8.60M6.29M10.40M-2.28M11.90M5.68M-27.91M-57.40M-29.96M18.49M-22.84M7.98M10.10M
Interest ExpensesInt Expense
Tax Rate
18.38%8.09%16.70%15.72%18.41%9.24%42.57%28.59%28.59%9.95%-51.02%28.59%24.16%-5.25%0.50%35.13%52.72%86.20%36.65%26.90%